Polarean Imaging (POLX) Share Price, News & Analysis

Company Overview

Polarean Imaging plc operates as a drug-device manufacturer and service provider for noble gas polarizer devices in Canada, the United Kingdom, and the United States. The company engages in the research, development, and commercialization of novel imaging solutions with a non-invasive and radiation-free functional imaging platform. It also offers XENOVIEW, a hyperpolarized contrast agent indicated for use with magnetic resonance imaging (MRI) for evaluation of lung ventilation in adults and pediatric patients aged 12 years and older; and measurement station, chest coil, and dose delivery inhalation bags. Polarean Imaging plc was incorporated in 2016 and is based in Durham, North Carolina.

Key Stats

• Today's Range: 1.51 to 1.55
• 50-Day Range: 1.24 to 1.82
• 52-Week Range: 1 to 8.50
• Volume: 457,959 shs
• Average Volume: 7.16 million shs
• Market Capitalization: £18.31 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

POLX Stock Analysis - Frequently Asked Questions

How have POLX shares performed this year?

Polarean Imaging's stock was trading at GBX 6.25 on January 1st, 2024. Since then, POLX stock has decreased by 75.8% and is now trading at GBX 1.51.
View the best growth stocks for 2024 here.

How do I buy shares of Polarean Imaging?

Shares of POLX stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What other stocks do shareholders of Polarean Imaging own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Polarean Imaging investors own include SSP Group (SSPG), Intel (INTC), Allena Pharmaceuticals (ALNA), ASOS (ASC), B&M European Value Retail (BME), BP (BP) and Coats Group (COA).

Industry, Sector and Symbol

• Stock Exchange: LON
• Sector: Medical
• Industry: Medical Devices
• Sub-Industry: N/A
• Current Symbol: LON:POLX
• CUSIP: N/A
• CIK: N/A
• Web: www.polarean.com
• Phone: 919 206 7900
• Fax: N/A
• Employees: 28
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): GBX (0.02)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: £-8,550,000.00
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: -60.59%
• Return on Assets: -32.28%

Debt

• Debt-to-Equity Ratio: 0.93
• Current Ratio: 5.90
• Quick Ratio: 9.80

Sales & Book Value

• Annual Sales: £1.87 million
• Price / Sales: 9.89
• Cash Flow: GBX 0.31 per share
• Price / Cash Flow: 4.93
• Book Value: GBX 1 per share
• Price / Book: 1.53

Miscellaneous

• Outstanding Shares: 1,210,000,000
• Free Float: N/A
• Market Cap: £18.50 million
• Optionable: Not Optionable
• Beta: 0.38